title: Position statement of the CSCC and CAP Task Force on the measurement of lipids for the assessment of risk of CHD.
authors.forename: A
authors.initials: A
authors.lastname: Dinwoodie
authors.forename: J
authors.initials: J
authors.lastname: Frohlich
authors.forename: G
authors.initials: G
authors.lastname: Hoag
authors.forename: A W
authors.initials: AW
authors.lastname: Luxton
authors.forename: M
authors.initials: M
authors.lastname: McQueen
authors.forename: B
authors.initials: B
authors.lastname: Rasaiah
authors.forename: M L
authors.initials: ML
authors.lastname: Salkie
mesh_terms: D008076:Cholesterol, HDL / Q000032:analysis; D008078:Cholesterol, LDL / Q000032:analysis; D003327:Coronary Disease / Q000517:prevention & control*; D003625:Data Collection; D003627:Data Interpretation, Statistical; D006801:Humans; D007753:Laboratories; D008055:Lipids / Q000032:analysis*; D011786:Quality Control; D012307:Risk Factors; D013048:Specimen Handling; D014938:Work Capacity Evaluation
chemical_list: D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D008055:Lipids